Nara-ken, Japan

Yasushi Itakura


Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Nara, JP (2002)
  • Nara-ken, JP (2004)

Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yasushi Itakura: Innovator in Pancreatic Function Disorders

Introduction

Yasushi Itakura is a prominent inventor based in Nara-ken, Japan. He has made significant contributions to the field of medical science, particularly in the area of pancreatic function disorders. With a total of 2 patents, his work focuses on innovative treatments that aim to improve health outcomes for patients suffering from various pancreatic conditions.

Latest Patents

Yasushi Itakura's latest patents include an agent for ameliorating pancreatic function disorder. This agent contains a neurotrophic factor such as BDNF, which is effective in preventing and treating degenerative dropout of pancreatic cells and pancreatic hypofunction caused by diabetes and pancreatitis. Another notable patent involves a composition containing ascorbic acid and its derivatives, which can reduce lactic acid levels in the blood. This composition is particularly useful for treating lactic acidosis caused by various medications and conditions.

Career Highlights

Yasushi Itakura is associated with Sumitomo Pharmaceuticals Company Limited, where he has been instrumental in advancing research and development in pharmaceutical innovations. His work has garnered attention for its potential to significantly impact the treatment of pancreatic disorders.

Collaborations

Yasushi Itakura has collaborated with notable colleagues, including Mutsuo Taiji and Hiroshi Noguchi. These partnerships have contributed to the successful development of his innovative patents.

Conclusion

Yasushi Itakura's contributions to the field of pancreatic function disorders highlight his role as a leading inventor in medical science. His innovative patents reflect a commitment to improving patient care and advancing therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…